108 related articles for article (PubMed ID: 10961801)
1. Use of methotrexate for autoimmune hearing loss.
Matteson EL; Tirzaman O; Facer GW; Fabry DA; Kasperbauer J; Beatty CW; McDonald TJ
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):710-4. PubMed ID: 10961801
[TBL] [Abstract][Full Text] [Related]
2. Open trial of methotrexate as treatment for autoimmune hearing loss.
Matteson EL; Fabry DA; Facer GW; Beatty CW; Driscoll CL; Strome SE; McDonald TJ
Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
[TBL] [Abstract][Full Text] [Related]
3. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
[TBL] [Abstract][Full Text] [Related]
4. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate management of immune-mediated cochleovestibular disorders.
Sismanis A; Wise CM; Johnson GD
Otolaryngol Head Neck Surg; 1997 Feb; 116(2):146-52. PubMed ID: 9051055
[TBL] [Abstract][Full Text] [Related]
7. Recovery of Hearing in Meniere's Disease after Antiviral Treatment.
Gacek RR
Am J Otolaryngol; 2015; 36(3):315-23. PubMed ID: 25940200
[TBL] [Abstract][Full Text] [Related]
8. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
9. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
10. Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach.
García-Berrocal JR; Ibáñez A; Rodríguez A; González-García JA; Verdaguer JM; Trinidad A; Ramírez-Camacho R
Eur Arch Otorhinolaryngol; 2006 Nov; 263(11):977-82. PubMed ID: 16802138
[TBL] [Abstract][Full Text] [Related]
11. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients.
Salley LH; Grimm M; Sismanis A; Spencer RF; Wise CM
J Rheumatol; 2001 May; 28(5):1037-40. PubMed ID: 11361185
[TBL] [Abstract][Full Text] [Related]
13. Titration streptomycin therapy in Meniere's disease: long-term results.
Balyan FR; Taibah A; De Donato G; Aslan A; Falcioni M; Russo A; Sanna M
Otolaryngol Head Neck Surg; 1998 Feb; 118(2):261-6. PubMed ID: 9482564
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of acetazolamide and chlorthalidone on the hearing loss of Menière's disease.
Corvera J; Corvera G
Am J Otol; 1989 Mar; 10(2):142-5. PubMed ID: 2735386
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
17. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
[TBL] [Abstract][Full Text] [Related]
18. [Intratympanic gentamicin in Menière's disease].
Huang W; Xu H; Gao B
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
[TBL] [Abstract][Full Text] [Related]
19. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
20. Cochlear microphonics in Ménière's disease.
Ge NN; Shea JJ; Orchik DJ
Am J Otol; 1997 Jan; 18(1):58-66. PubMed ID: 8989953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
